This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Ecole Normale Superieure De Lyon, National Institute of Health and Medical Research. Active years: 2025.
Company Filing History:
1 out of 5,383 
1 out of 44 
1 out of 1,853 
Years Active: 2025
Title: The Innovative Contributions of Blandine Padey
Introduction
Blandine Padey is a notable inventor based in Lyons, France. She has made significant contributions to the field of medicine, particularly in the area of viral infections. Her work focuses on innovative therapeutic combinations that can enhance treatment efficacy.
Latest Patents
Blandine Padey holds a patent for a unique combination of Diltiazem and viral polymerase inhibitors. This invention relates to the therapeutic use of this combination in the prevention and treatment of viral infections, specifically targeting the respiratory and intestinal tracts in humans and animals. The patent highlights the potential of using Diltiazem alongside compounds such as Baloxavir marboxil, Pimodivir, RO-7, and CC-42344.
Career Highlights
Throughout her career, Blandine Padey has been associated with prestigious institutions such as Université Claude Bernard Lyon 1 and the Institut National de la Santé et de la Recherche Médicale (Inserm). Her work at these institutions has allowed her to advance her research and contribute to significant medical advancements.
Collaborations
Blandine has collaborated with esteemed colleagues, including Olivier Terrier and Manuel Rosa-Calatrava. These partnerships have fostered a collaborative environment that enhances the research and development of innovative medical solutions.
Conclusion
Blandine Padey's contributions to the field of medicine through her innovative patent demonstrate her commitment to improving therapeutic options for viral infections. Her work continues to inspire advancements in medical research and treatment methodologies.